Leadership

Mark A. Nelson, Ph.D.

Chief Executive Officer

Co-Founder DesertDx, LLC.  Current Position: Professor Pathology positions and Co-Director of Pathology Tissue Core.  Previously held positions. Director of Research of the Department of Pathology, Co-Program Leader of Gastrointestinal Cancer Program, Co-Director Tissue Acquisition and Cellular/Molecular Analysis Shared Service, Director Gastrointestinal Program Tissue Resource.  Hogarty Family Foundation Award Winner with over 30 years of experience in cancer biology.

Bernard Futscher, Ph.D.

Chief Scientific Officer

Co-Founder DesertDx, LLC.  Inventor of DesertDx technology.  Professor of Pharmacology and Toxicology and Scientific Director of the Arizona Cancer Genomics Shared Resource. Maynard Chair in Breast Cancer Epigenomics. Recipient of G.D. Searle Fellowship, Arthur J, Schmitt Fellowship, and Susan B. Koman Fellowship. Current research interest- Understanding epigenetic dysfunction in human cancer. Over 30 years of experience in cancer biology.  

Corey Hill, MBA

Chief Business Officer

Current Position: Strategic Planning Director, Olympics & Athletes for NIKE. Previously held position, Finance and Strategy Director for NIKE North America, Land Acquisition Manager, Finance Manager for KB homes, Finance and Strategic Planning Raytheon Missile Systems.

Gary Clarke, PMD

Chief Investment Officer/Financial Officer

Mr. Clarke has twenty-five years of executive leadership experience building award-winning companies as an early employee and founder with legendary and pioneering startups that changed the world. He is recognized for crafting strategies to seize opportunities, by developing business models, forging partnerships, and executing plans to create billions of dollars of market value across Biotech, SaaS, Clean Tech, and Marketplaces. He has a solid foundation in finance, operations, technology, and business development.